Get the Daily Brief
Latest Biotech News
FDA Clears Pembrolizumab as Neoadjuvant for Head and Neck Cancer
The FDA approved pembrolizumab for patients with resectable locally advanced head and neck squamous cell carcinoma expressing PD-L1 (CPS ≥1), based on the pivotal KEYNOTE-689 phase 3 trial....
23andMe Assets Acquired by Anne Wojcicki’s Research Nonprofit
Anne Wojcicki's TTAM Research Institute won a $305 million bidding war to acquire most assets of 23andMe, surpassing Regeneron’s $256 million offer. The agreement preserves strong consumer privacy...
Rapid Vascular Organoid Generation via Dual Transcription Factor Activation
Researchers from Boston Children’s Hospital and Harvard Medical School developed a rapid, defined method to create functional vascular organoids by simultaneously activating endothelial and mural...
Quantum Simulation Reveals Stability of Quasicrystals
University of Michigan scientists performed the first quantum-mechanical simulations to explain the fundamental stability of quasicrystals, solids exhibiting non-repeating atomic lattices and...
AI-Powered Podcasts Enhance Science Communication
A study at the University of Leuven demonstrated the effectiveness of AI-generated podcasts in summarizing scientific research, with many authors unable to distinguish them from human-hosted...
New Biomaterial Reverses Aging Effects in Heart Cells
Researchers at the National University of Singapore developed a hybrid biomaterial platform, DECIPHER, combining natural heart extracellular matrix with synthetic hydrogels to decouple and control...
Advances in Multiomics Integration via Proteomics Partnerships
Proteomics integration with sequencing technologies is advancing multiomics capabilities as firms like Ultima Genomics, Olink Proteomics, and SomaLogic collaborate to pair gene sequencing with...
KalVista Faces FDA Delay on Hereditary Angioedema Drug Approval
KalVista Pharmaceuticals announced an FDA delay in the decision on approval of its oral on-demand treatment for hereditary angioedema, attributing the postponement to agency workload and limited...
Hybrid Cooling Technology Offers Energy Efficient Solution for Data Centers
UC San Diego engineers developed a novel evaporative cooling technology employing a low-cost fiber membrane with interconnected pores that passively removes heat from electronics through...
Sarepta Pauses Duchenne Gene Therapy After Second Patient Death
Sarepta Therapeutics halted delivery of its gene therapy Elevidys for Duchenne muscular dystrophy patients who are non-ambulatory after the second fatal liver failure case. The company is working...
Anne Wojcicki’s Nonprofit Tops 23andMe Asset Auction
Anne Wojcicki’s nonprofit TTAM Research Institute secured 23andMe’s assets for $305 million, surpassing Regeneron’s bid in bankruptcy court proceedings. The acquisition includes commitments to...
ADC Therapeutics Cuts UK Site and 30% Workforce After Trial Failures
After discontinuing its only clinical-stage candidate and several preclinical solid tumor programs, ADC Therapeutics announced the closure of its UK research site and 30% workforce reduction. This...
Sarepta Halts Duchenne Gene Therapy Shipments After Second Death
Sarepta Therapeutics has ceased shipments of its Duchenne muscular dystrophy gene therapy Elevidys for non-ambulatory patients following a second fatality due to acute liver failure. Both deaths...
New Biomarkers and Mechanisms in Parkinson’s Disease Research
Recent studies published in npj Parkinson’s Disease and others reveal advancements in understanding Parkinson’s disease pathology, including the role of cutaneous nerve fibers and brain...
FDA Approves Checkpoint Inhibitor for Head and Neck Cancer
The FDA has approved pembrolizumab for patients with resectable locally advanced head and neck squamous cell carcinoma expressing PD-L1, based on the phase 3 KEYNOTE-689 trial. The regimen of...
Rapid Vascular Organoid Generation Advances Regenerative Medicine
Researchers from Boston Children’s Hospital and collaborators have developed a method accelerating vascular organoid formation from human iPSCs by dual transcription factor activation. This...
Anne Wojcicki’s Nonprofit Wins 23andMe Bidding War
Anne Wojcicki, co-founder and former CEO of 23andMe, through her nonprofit TTAM Research Institute, outbid Regeneron with a $305 million offer for the genetic testing company’s assets. The...
Innovations in Multiomics and Proteomics Technology Integration
The multiomics field is evolving as companies prioritize combining gene sequencing with proteomics. Collaborations like those between Ultima Genomics and Olink, and Illumina with SomaLogic,...
Quantum Simulation Breakthrough Illuminates Particle 'String Breaking'
Two international teams using quantum computers—one at QuEra Computing and another at Google Quantum AI Lab—have successfully simulated the real-time phenomenon of particle string breaking, where...
New Cooling Technology Promises Energy Efficiency for Data Centers
Engineers at UC San Diego have developed a novel evaporative cooling device using fiber membranes that passively dissipate heat from electronics. This system, described in Joule, could markedly...